Connect Biopharma Holdings (CNTB)

• Market cap: $101M
• 1 day: -2.15%
• 5 days: 8.33%
• 1 month: 13.75%
• 3 months: 29.08%
• 6 months: 179.61%
• Year to date: 50.41%
• 1 year: 30%
• 5 years: -90.16%
• 10 years: -90.16%
• Sector: Healthcare
• Industry: Biotechnology

About: Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Employees: 62